Susquehanna International Group, LLP Co Diagnostics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.02 - $1.75 $11,934 - $20,475	11,700 New	11,700 $14,000
Q1 2023 May 16, 2023	BUY	$1.39 - $3.24 $5,699 - $13,284	4,100 Added 13.02%	35,600 $52,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $324,800 - $515,200	-140,000 Reduced 81.63%	31,500 $79,000
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $689,661 - $1.68 Million	-240,300 Reduced 58.35%	171,500 $551,000
Q2 2022 Aug 15, 2022	BUY	$3.76 - $6.29 $530,536 - $887,519	141,100 Added 52.12%	411,800 $2.31 Million
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $780,656 - $1.49 Million	155,200 Added 134.37%	270,700 $1.67 Million
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $239,539 - $305,915	-29,500 Reduced 20.34%	115,500 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $528,836 - $804,566	70,700 Added 95.15%	145,000 $1.41 Million
Q2 2021 Aug 11, 2021	SELL	$7.16 - $9.56 $62,292 - $83,172	-8,700 Reduced 10.48%	74,300 $613,000
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $1.91 Million - $4.31 Million	-224,400 Reduced 73.0%	83,000 $792,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $15.19 $924,420 - $1.51 Million	99,400 Added 47.79%	307,400 $2.86 Million
Q3 2020 Nov 16, 2020	SELL	$8.24 - $30.8 $2.27 Million - $8.48 Million	-275,400 Reduced 56.97%	208,000 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $2.63 Million - $8.26 Million	352,800 Added 270.14%	483,400 $9.35 Million
Q1 2020 May 15, 2020	BUY	$0.91 - $17.81 $118,846 - $2.33 Million	130,600 New	130,600 $995,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.